Literature DB >> 17033376

Skin and soft tissue infection: necrotizing fasciitis.

D E Low1, A McGeer.   

Abstract

The incidence of necrotizing fasciitis has increased in the past decade as a result of the resurgence severe group A streptococcal infection. Mortality has remained unchanged over the past 60 years, supporting the notion that immune modulators, such as intravenous immunoglobulin, are required to alter the physiological process during the early stages of infection.

Entities:  

Year:  1998        PMID: 17033376     DOI: 10.1097/00001432-199804000-00005

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  6 in total

1.  Bowel Perforation Resulting in Necrotizing Soft-Tissue Infection of the Abdomen, Flank, and Lower Extremities.

Authors:  Disha Kumar; Nicolás W Cortés-Penfield; Hanine El-Haddad; Daniel M Musher
Journal:  Surg Infect (Larchmt)       Date:  2018-06-12       Impact factor: 2.150

Review 2.  Necrotizing soft tissue infections.

Authors:  J D Urschel
Journal:  Postgrad Med J       Date:  1999-11       Impact factor: 2.401

Review 3.  Necrotising fasciitis due to an infected sebaceous cyst.

Authors:  W M P F Bosman; W Brekelmans; P S Verduijn; B L S Borger van der Burg; E D Ritchie
Journal:  BMJ Case Rep       Date:  2014-04-30

4.  Multidisciplinary management of periocular necrotising fasciitis: a series of 11 patients.

Authors:  K Tambe; A Tripathi; J Burns; R Sampath
Journal:  Eye (Lond)       Date:  2011-12-09       Impact factor: 3.775

5.  Triple diagnostics for early detection of ambivalent necrotizing fasciitis.

Authors:  Falco Hietbrink; Lonneke G Bode; Louis Riddez; Luke P H Leenen; Marijke R van Dijk
Journal:  World J Emerg Surg       Date:  2016-10-11       Impact factor: 5.469

6.  Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.

Authors:  Fredrik Kahn; Matthias Mörgelin; Oonagh Shannon; Anna Norrby-Teglund; Heiko Herwald; Anders I Olin; Lars Björck
Journal:  PLoS Pathog       Date:  2008-09-12       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.